Literature DB >> 10489374

Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.

J Roose1, G Huls, M van Beest, P Moerer, K van der Horn, R Goldschmeding, T Logtenberg, H Clevers.   

Abstract

Mutations in APC or beta-catenin inappropriately activate the transcription factor Tcf4, thereby transforming intestinal epithelial cells. Here it is shown that one of the target genes of Tcf4 in epithelial cells is Tcf1. The most abundant Tcf1 isoforms lack a beta-catenin interaction domain. Tcf1(-/-) mice develop adenomas in the gut and mammary glands. Introduction of a mutant APC allele into these mice substantially increases the number of these adenomas. Tcf1 may act as a feedback repressor of beta-catenin-Tcf4 target genes and thus may cooperate with APC to suppress malignant transformation of epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489374     DOI: 10.1126/science.285.5435.1923

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  169 in total

1.  Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin.

Authors:  B J Merrill; U Gat; R DasGupta; E Fuchs
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

Review 2.  T-cell factors: turn-ons and turn-offs.

Authors:  Adam Hurlstone; Hans Clevers
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

3.  gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.

Authors:  F T Kolligs; B Kolligs; K M Hajra; G Hu; M Tani; K R Cho; E R Fearon
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

4.  Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators.

Authors:  K Kim; K M Pang; M Evans; E D Hay
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 5.  Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.

Authors:  Catherine D Mao; Stephen W Byers
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 6.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

7.  A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs.

Authors:  Nate P Hoverter; Ju-Hui Ting; Suman Sundaresh; Pierre Baldi; Marian L Waterman
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

Review 8.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

9.  Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.

Authors:  Andy J Chien; Erin C Moore; Anke S Lonsdorf; Rima M Kulikauskas; Bonnie Gould Rothberg; Aaron J Berger; Michael B Major; Sam T Hwang; David L Rimm; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

10.  Evidence for association of the TCF7 locus with type I diabetes.

Authors:  H A Erlich; A M Valdes; C Julier; D Mirel; J A Noble
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.